Gilead Licenses Long-Acting HIV Prevention Drug to Generics Firms
- Posted on October 2, 2024
- By Bing News
- 1 Views
Gilead Licenses Long-Acting HIV Prevention Drug to Generics Firms
Gilead Sciences Inc. said it is licensing its twice-yearly experimental HIV prevention drug lenacapavir to six generics makers after coming under fire from HIV advocates who argued the company was prioritizing profit over patients.
